PRESS RELEASE published on 06/10/2026 at 07:30, 3 months 8 days ago Inside Information / Other news releases Sensorion achieves key regulatory milestones for SENS-601 addressing GJB2-related hearing loss and discontinues SENS-501. Fast Track procedure granted by ANSM in France. Clinical trials planned in Canada and U.S. IND submission targeted by 2026 Clinical Trials Gene Therapy Sensorion Regulatory Milestones GJB2-related Hearing Loss
BRIEF published on 05/18/2026 at 07:35, 4 months ago Fred Chereau appointed Managing Director of Sensorion Gene Therapy General Management Hearing Loss Sensory Fred Chereau
BRIEF published on 05/18/2026 at 07:35, 4 months ago Sensorion Appoints Fred Chereau as CEO Biotechnology CEO Appointment Gene Therapy Sensorion Fred Chereau
PRESS RELEASE published on 05/18/2026 at 07:30, 4 months ago Inside Information / Other news releases Sensorion appoints Fred Chereau as Chief Executive Officer, bringing extensive leadership experience in gene therapy and rare diseases. Amit Munshi continues as Chairman of the Board Gene Therapy Chief Executive Officer Rare Diseases Sensorion Fred Chereau
BRIEF published on 05/13/2026 at 07:35, 4 months 5 days ago Results of the Sensorion General Meeting Biotechnology General Assembly Resolutions Adopted Hearing Loss Sensory
PRESS RELEASE published on 05/13/2026 at 07:30, 4 months 5 days ago Inside Information / Other news releases Sensorion releases results of Combined General Meeting resolutions. All recommended resolutions adopted with 77.83% capital presence. Details available on website Shareholders General Meeting Resolutions Sensorion Hearing Loss
BRIEF published on 05/05/2026 at 07:35, 4 months 13 days ago Sensorion is participating in the ASGCT annual conference Gene Therapy Hearing Loss SENS-601 Sensory ASGCT 2026
BRIEF published on 05/05/2026 at 07:35, 4 months 13 days ago Sensorion Participates in ASGCT Annual Meeting Biotechnology Gene Therapy Sensorion Hearing Loss ASGCT 2026
PRESS RELEASE published on 05/05/2026 at 07:30, 4 months 13 days ago Inside Information / Other news releases Sensorion announces participation in ASGCT Annual Meeting to present gene therapy treatments for hereditary deafness Gene Therapy Innovative Treatments Sensorion ASGCT Annual Meeting Hereditary Deafness
BRIEF published on 04/21/2026 at 07:35, 4 months 27 days ago Sensorion is preparing for its Annual General Meeting Shareholders General Assembly Preparatory Documents Remote Voting Sensory
Published on 09/18/2026 at 06:30, 2 hours 4 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/18/2026 at 00:55, 7 hours 39 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 8 hours 9 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 10 hours 19 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/18/2026 at 08:10, 24 minutes ago NORMA Group successfully completes second public share buyback offer with a repurchase volume of approximately EUR 208 million
Published on 09/18/2026 at 08:05, 29 minutes ago THE TOKYO PASS Renews Official Website, Redefining Wellness Tourism in Tokyo with "Museum Bathing (R)"
Published on 09/17/2026 at 17:40, 14 hours 54 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 14 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 2 days 1 hour ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
